Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / Fund iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
Issuer Blackrock
Entity holding fund iShares VII Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF Ticker CUS1(GBX) LSE
ETF Ticker CUSS(USD) LSE
ETF Ticker SXRG(EUR) F
ETF Ticker CSUSS.MI(EUR) CXE
ETF Ticker CSUSSz(USD) CXE
ETF Ticker CUSS.LS(USD) CXE
ETF Ticker CSUSS(EUR) ETF Plus
ETF Ticker CUS1.L(GBP) LSE
ETF Ticker CUSS.L(GBP) LSE

Holdings detail for AMPH

Stock Name	Amphastar P
Ticker	AMPH(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US03209R1032
LEI	54930055TH0ZLSAQMJ38

Show aggregate AMPH holdings

News associated with AMPH

Amphastar Pharmaceuticals (NASDAQ:AMPH) Given New $32.00 Price Target at Bank of America: Amphastar Pharmaceuticals (NASDAQ:AMPH – Free Report) had its target price upped by Bank of America from $28.00 to $32.00 in a research report report published on Tuesday,Benzinga reports. They currently have a neutral rating on the stock. Several other research firms also recently weighed in on AMPH. JPMorgan Chase & Co. reissued a “neutral” rating […] - 2025-08-27 02:52:54
Amphastar Pharmaceuticals (NASDAQ:AMPH) vs. Personalis (NASDAQ:PSNL) Financial Contrast: Amphastar Pharmaceuticals (NASDAQ:AMPH – Get Free Report) and Personalis (NASDAQ:PSNL – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, risk, dividends, valuation and earnings. Volatility and Risk Amphastar Pharmaceuticals has a beta […] - 2025-08-20 02:55:13
Piper Sandler Cuts Amphastar Pharmaceuticals (NASDAQ:AMPH) Price Target to $25.00: Amphastar Pharmaceuticals (NASDAQ:AMPH – Free Report) had its price target trimmed by Piper Sandler from $30.00 to $25.00 in a report issued on Friday morning,Benzinga reports. The brokerage currently has a neutral rating on the stock. Other analysts have also issued reports about the stock. Needham & Company LLC reissued a “hold” rating on shares […] - 2025-08-11 03:08:44
The Math Shows IJS Can Go To $119: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-08-07 08:57:20
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Stake Raised by Victory Capital Management Inc.: Victory Capital Management Inc. grew its stake in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 27.9% in the first quarter, Holdings Channel.com reports. The fund owned 81,087 shares of the company’s stock after buying an additional 17,700 shares during the quarter. Victory Capital Management Inc.’s holdings in Amphastar Pharmaceuticals were worth $2,351,000 […] - 2025-07-29 04:20:54
New York State Common Retirement Fund Acquires 11,075 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH): New York State Common Retirement Fund lifted its stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 15.7% in the 1st quarter, HoldingsChannel reports. The institutional investor owned 81,565 shares of the company’s stock after purchasing an additional 11,075 shares during the quarter. New York State Common Retirement Fund’s holdings in Amphastar Pharmaceuticals were […] - 2025-07-24 04:40:46
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 493,214 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH): UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lessened its holdings in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 85.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 83,231 shares of the company’s […] - 2025-06-06 04:42:49
Squarepoint Ops LLC Buys 11,929 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH): Squarepoint Ops LLC grew its stake in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 208.0% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 17,664 shares of the company’s stock after purchasing an additional 11,929 shares during the period. Squarepoint Ops […] - 2025-06-03 05:38:56
Nuveen Asset Management LLC Sells 112,307 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH): Nuveen Asset Management LLC trimmed its position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 54.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 95,665 shares of the company’s stock after selling 112,307 shares during the quarter. Nuveen Asset Management LLC’s holdings […] - 2025-06-02 05:04:53
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Sold by Two Sigma Investments LP: Two Sigma Investments LP lowered its position in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 0.6% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 98,184 shares of the company’s stock after selling 614 shares during the quarter. Two Sigma Investments LP’s holdings in Amphastar Pharmaceuticals were worth $3,646,000 as of […] - 2025-05-29 05:14:54
Two Sigma Advisers LP Sells 12,400 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH): Two Sigma Advisers LP lessened its position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 12.6% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 85,900 shares of the company’s stock after selling 12,400 shares during the period. Two Sigma Advisers LP’s holdings in Amphastar Pharmaceuticals were worth $3,189,000 as of its most […] - 2025-05-27 05:57:02
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Sold by The Manufacturers Life Insurance Company: The Manufacturers Life Insurance Company trimmed its stake in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 2.8% in the 4th quarter, HoldingsChannel reports. The firm owned 21,257 shares of the company’s stock after selling 610 shares during the period. The Manufacturers Life Insurance Company’s holdings in Amphastar Pharmaceuticals were worth $789,000 as […] - 2025-05-15 04:45:07
Northern Trust Corp Purchases 29,808 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH): Northern Trust Corp raised its position in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 5.1% in the fourth quarter, HoldingsChannel reports. The firm owned 613,170 shares of the company’s stock after acquiring an additional 29,808 shares during the period. Northern Trust Corp’s holdings in Amphastar Pharmaceuticals were worth $22,767,000 as of its […] - 2025-05-13 05:28:51
Hsbc Holdings PLC Boosts Stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH): Hsbc Holdings PLC lifted its holdings in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 23.4% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 8,991 shares of the company’s stock after purchasing an additional 1,707 shares during the quarter. […] - 2025-05-09 05:41:01
Analysts Forecast 23% Gains Ahead For IJT: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-05-05 08:57:34
First Trust Advisors LP Raises Stock Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH): First Trust Advisors LP boosted its stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 350.0% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 81,129 shares of the company’s stock after purchasing an additional 63,100 shares during the quarter. […] - 2025-05-04 05:30:50
Barclays PLC Acquires 10,334 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH): Barclays PLC lifted its holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 13.9% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 84,790 shares of the company’s stock after acquiring an additional 10,334 shares during the period. Barclays PLC’s holdings […] - 2025-04-30 05:12:50
Raymond James Financial Inc. Invests $3.45 Million in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH): Raymond James Financial Inc. purchased a new stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 92,904 shares of the company’s stock, valued at approximately $3,450,000. Raymond James Financial Inc. owned approximately 0.19% of Amphastar […] - 2025-04-28 05:06:47
Vanguard Group Inc. Has $100.79 Million Stock Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH): Vanguard Group Inc. increased its stake in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 0.1% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 2,714,628 shares of the company’s stock after acquiring an additional 3,155 shares during the quarter. Vanguard Group Inc. owned 0.06% of Amphastar Pharmaceuticals worth $100,794,000 as of […] - 2025-04-10 04:38:49
American Century Companies Inc. Decreases Stock Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH): American Century Companies Inc. lessened its holdings in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 26.2% in the fourth quarter, Holdings Channel.com reports. The fund owned 472,017 shares of the company’s stock after selling 167,575 shares during the period. American Century Companies Inc.’s holdings in Amphastar Pharmaceuticals were worth $17,526,000 at the […] - 2025-04-01 05:38:53
Thrivent Financial for Lutherans Cuts Stock Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH): Thrivent Financial for Lutherans reduced its stake in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 2.8% during the fourth quarter, Holdings Channel reports. The institutional investor owned 28,988 shares of the company’s stock after selling 827 shares during the quarter. Thrivent Financial for Lutherans’ holdings in Amphastar Pharmaceuticals were worth $1,076,000 at […] - 2025-04-01 04:40:47
Victory Capital Management Inc. Sells 155,144 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH): Victory Capital Management Inc. cut its stake in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 71.0% in the 4th quarter, Holdings Channel.com reports. The fund owned 63,387 shares of the company’s stock after selling 155,144 shares during the period. Victory Capital Management Inc.’s holdings in Amphastar Pharmaceuticals were worth $2,354,000 as of […] - 2025-03-18 05:41:08
AlphaQuest LLC Reduces Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH): AlphaQuest LLC reduced its holdings in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 35.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,862 shares of the company’s stock after selling 2,724 shares during the period. AlphaQuest […] - 2025-03-17 06:03:06
Smartleaf Asset Management LLC Buys 493 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH): Smartleaf Asset Management LLC grew its stake in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 222.1% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 715 shares of the company’s stock after purchasing an additional 493 shares during the quarter. Smartleaf Asset Management LLC’s holdings in Amphastar Pharmaceuticals were worth $26,000 […] - 2025-03-13 05:54:49
Assetmark Inc. Decreases Stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH): Assetmark Inc. reduced its stake in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 4.5% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 41,921 shares of the company’s stock after selling 1,985 shares during the period. Assetmark Inc.’s holdings in Amphastar Pharmaceuticals were […] - 2025-03-11 06:20:51
Amphastar Pharmaceuticals (NASDAQ:AMPH) Lowered to “Neutral” Rating by Piper Sandler: Piper Sandler cut shares of Amphastar Pharmaceuticals (NASDAQ:AMPH – Free Report) from an overweight rating to a neutral rating in a research note issued to investors on Tuesday, Marketbeat reports. They currently have $36.00 price target on the stock, down from their previous price target of $66.00. A number of other equities research analysts also […] - 2025-02-05 06:38:50

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc AMPH holdings

Date	Number of AMPH Shares Held	Base Market Value of AMPH Shares	Local Market Value of AMPH Shares	Change in AMPH Shares Held	Change in AMPH Base Value	Current Price per AMPH Share Held	Previous Price per AMPH Share Held
2025-09-26 (Friday)	4,339	USD 116,502	USD 116,502
2025-09-25 (Thursday)	4,339	USD 114,376	USD 114,376	0	USD -2,213	USD 26.36	USD 26.87
2025-09-24 (Wednesday)	4,339	USD 116,589	USD 116,589
2025-09-17 (Wednesday)	4,311	USD 116,311	USD 116,311	0	USD -86	USD 26.9801	USD 27
2025-09-16 (Tuesday)	4,311	USD 116,397	USD 116,397
2025-09-12 (Friday)	4,283	USD 120,181	USD 120,181
2025-09-11 (Thursday)	4,283	USD 122,836	USD 122,836

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of AMPH by Blackrock for IE00B3VWM098

Show aggregate share trades of AMPH

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-08-21 SELL -14 29.660* 30.79 Profit of 431 on sale
2025-07-31 BUY 42 20.950* 30.86
2025-06-30 SELL -28 22.960* 31.97 Profit of 895 on sale
2025-06-25 SELL -14 23.450* 32.16 Profit of 450 on sale
2025-06-20 SELL -28 24.560* 32.32 Profit of 905 on sale
2025-05-23 BUY 14 24.470* 33.41
2025-05-19 SELL -14 24.790* 33.71 Profit of 472 on sale
2025-05-15 SELL -42 24.320* 33.87 Profit of 1,423 on sale
2025-05-12 SELL -14 24.340* 34.14 Profit of 478 on sale
2025-05-09 SELL -14 24.110* 34.23 Profit of 479 on sale
2025-04-30 SELL -14 24.410* 34.89 Profit of 488 on sale
2025-04-24 SELL -28 24.070* 35.32 Profit of 989 on sale
2025-04-17 SELL -14 23.350* 35.94 Profit of 503 on sale
2025-04-15 SELL -42 23.500* 36.21 Profit of 1,521 on sale
2025-04-14 SELL -42 24.420* 36.34 Profit of 1,526 on sale
2025-04-09 SELL -56 25.230* 36.74 Profit of 2,058 on sale
2025-04-07 SELL -98 25.000* 37.03 Profit of 3,629 on sale
2025-04-04 SELL -140 26.610* 37.15 Profit of 5,201 on sale
2025-03-31 BUY 14 28.990* 37.47
2025-03-19 SELL -28 27.860* 38.45 Profit of 1,077 on sale
2025-03-14 SELL -84 26.660* 38.91 Profit of 3,269 on sale
2025-03-13 SELL -28 26.240* 39.09 Profit of 1,095 on sale
2025-03-12 SELL -476 26.280* 39.28 Profit of 18,695 on sale
2025-03-07 SELL -28 28.810* 39.77 Profit of 1,114 on sale
2025-03-06 SELL -42 28.320* 39.95 Profit of 1,678 on sale
2025-03-03 SELL -14 27.520* 40.53 Profit of 567 on sale
2025-02-28 SELL -84 28.430* 40.72 Profit of 3,421 on sale
2025-02-26 SELL -14 31.210* 41.03 Profit of 574 on sale
2025-02-25 SELL -42 31.990* 41.19 Profit of 1,730 on sale
2025-02-18 BUY 70 30.750* 42.30
2025-02-13 BUY 14 31.740* 42.97
2025-02-12 BUY 14 31.820* 43.19
2025-02-11 BUY 42 32.210* 43.42
2025-02-06 BUY 126 32.790* 44.15
2025-01-27 BUY 14 37.110* 46.10
2024-12-30 BUY 70 36.840* 47.26
2024-12-06 BUY 56 43.800* 47.61
2024-12-05 BUY 14 43.600* 47.75
2024-12-04 BUY 70 44.300* 47.87
2024-11-29 BUY 70 45.190* 48.17
2024-11-27 BUY 56 45.210* 48.43
2024-11-26 BUY 14 44.220* 48.62
2024-11-21 BUY 70 44.550* 49.21
2024-11-20 BUY 42 44.090* 49.50
2024-11-18 BUY 168 44.160* 50.20
2024-11-12 BUY 112 47.710* 50.37
2024-11-08 BUY 70 48.310* 50.51
2024-11-07 BUY 210 46.090* 50.85
2024-11-06 BUY 28 53.400* 50.64
2024-10-31 BUY 14 50.530* 50.54
Market high and low price is on the date.

Date	Action	Quantity	Likely Trade Price	Average Price previous trades
2025-08-21	SELL	-14	29.660*	30.79 Profit of 431 on sale
2025-07-31	BUY	42	20.950*	30.86
2025-06-30	SELL	-28	22.960*	31.97 Profit of 895 on sale
2025-06-25	SELL	-14	23.450*	32.16 Profit of 450 on sale
2025-06-20	SELL	-28	24.560*	32.32 Profit of 905 on sale
2025-05-23	BUY	14	24.470*	33.41
2025-05-19	SELL	-14	24.790*	33.71 Profit of 472 on sale
2025-05-15	SELL	-42	24.320*	33.87 Profit of 1,423 on sale
2025-05-12	SELL	-14	24.340*	34.14 Profit of 478 on sale
2025-05-09	SELL	-14	24.110*	34.23 Profit of 479 on sale
2025-04-30	SELL	-14	24.410*	34.89 Profit of 488 on sale
2025-04-24	SELL	-28	24.070*	35.32 Profit of 989 on sale
2025-04-17	SELL	-14	23.350*	35.94 Profit of 503 on sale
2025-04-15	SELL	-42	23.500*	36.21 Profit of 1,521 on sale
2025-04-14	SELL	-42	24.420*	36.34 Profit of 1,526 on sale
2025-04-09	SELL	-56	25.230*	36.74 Profit of 2,058 on sale
2025-04-07	SELL	-98	25.000*	37.03 Profit of 3,629 on sale
2025-04-04	SELL	-140	26.610*	37.15 Profit of 5,201 on sale
2025-03-31	BUY	14	28.990*	37.47
2025-03-19	SELL	-28	27.860*	38.45 Profit of 1,077 on sale
2025-03-14	SELL	-84	26.660*	38.91 Profit of 3,269 on sale
2025-03-13	SELL	-28	26.240*	39.09 Profit of 1,095 on sale
2025-03-12	SELL	-476	26.280*	39.28 Profit of 18,695 on sale
2025-03-07	SELL	-28	28.810*	39.77 Profit of 1,114 on sale
2025-03-06	SELL	-42	28.320*	39.95 Profit of 1,678 on sale
2025-03-03	SELL	-14	27.520*	40.53 Profit of 567 on sale
2025-02-28	SELL	-84	28.430*	40.72 Profit of 3,421 on sale
2025-02-26	SELL	-14	31.210*	41.03 Profit of 574 on sale
2025-02-25	SELL	-42	31.990*	41.19 Profit of 1,730 on sale
2025-02-18	BUY	70	30.750*	42.30
2025-02-13	BUY	14	31.740*	42.97
2025-02-12	BUY	14	31.820*	43.19
2025-02-11	BUY	42	32.210*	43.42
2025-02-06	BUY	126	32.790*	44.15
2025-01-27	BUY	14	37.110*	46.10
2024-12-30	BUY	70	36.840*	47.26
2024-12-06	BUY	56	43.800*	47.61
2024-12-05	BUY	14	43.600*	47.75
2024-12-04	BUY	70	44.300*	47.87
2024-11-29	BUY	70	45.190*	48.17
2024-11-27	BUY	56	45.210*	48.43
2024-11-26	BUY	14	44.220*	48.62
2024-11-21	BUY	70	44.550*	49.21
2024-11-20	BUY	42	44.090*	49.50
2024-11-18	BUY	168	44.160*	50.20
2024-11-12	BUY	112	47.710*	50.37
2024-11-08	BUY	70	48.310*	50.51
2024-11-07	BUY	210	46.090*	50.85
2024-11-06	BUY	28	53.400*	50.64
2024-10-31	BUY	14	50.530*	50.54

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of AMPH

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	55,746	0	114,920	48.5%
2025-09-18	89,175	0	173,571	51.4%
2025-09-17	443,239	0	520,396	85.2%
2025-09-16	111,916	0	181,523	61.7%
2025-09-15	73,007	0	149,659	48.8%
2025-09-12	43,242	0	96,384	44.9%
2025-09-11	54,598	6	115,305	47.4%
2025-09-10	52,436	0	97,936	53.5%
2025-09-09	77,348	0	171,128	45.2%
2025-09-08	72,877	0	141,509	51.5%
2025-09-05	91,062	191	167,757	54.3%
2025-09-04	157,722	0	260,189	60.6%
2025-09-03	81,108	70	186,896	43.4%
2025-09-02	100,246	0	148,267	67.6%
2025-08-29	62,588	0	116,356	53.8%
2025-08-28	37,162	0	118,423	31.4%
2025-08-27	54,039	0	103,859	52.0%
2025-08-26	56,817	0	129,492	43.9%
2025-08-25	46,898	0	143,082	32.8%
2025-08-22	64,010	0	166,916	38.3%
2025-08-21	69,745	0	185,491	37.6%
2025-08-20	63,196	69	138,131	45.8%
2025-08-19	122,547	33	187,477	65.4%
2025-08-18	70,958	250	167,869	42.3%
2025-08-15	166,026	0	240,160	69.1%
2025-08-14	99,059	17	175,554	56.4%
2025-08-13	218,969	29,560	374,491	58.5%
2025-08-12	405,106	0	607,751	66.7%
2025-08-11	340,139	4,251	644,080	52.8%
2025-08-08	168,545	281	406,787	41.4%
2025-08-07	168,531	0	307,604	54.8%
2025-08-06	78,935	21	144,127	54.8%
2025-08-05	47,066	0	138,569	34.0%
2025-08-04	67,680	0	152,924	44.3%
2025-08-01	91,414	0	174,789	52.3%
2025-07-31	109,003	0	200,472	54.4%
2025-07-30	45,189	0	124,579	36.3%
2025-07-29	84,995	1,699	128,557	66.1%
2025-07-28	101,436	0	189,517	53.5%
2025-07-25	34,129	0	120,024	28.4%
2025-07-24	32,423	0	97,434	33.3%
2025-07-23	102,110	0	207,046	49.3%
2025-07-22	73,751	567	161,842	45.6%
2025-07-21	89,992	0	161,387	55.8%
2025-07-18	70,001	0	152,262	46.0%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
Issuer	Blackrock
Entity holding fund	iShares VII Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300Q7FFITMZ2PFZ28
ETF Ticker	CUS1(GBX) LSE
ETF Ticker	CUSS(USD) LSE
ETF Ticker	SXRG(EUR) F
ETF Ticker	CSUSS.MI(EUR) CXE
ETF Ticker	CSUSSz(USD) CXE
ETF Ticker	CUSS.LS(USD) CXE
ETF Ticker	CSUSS(EUR) ETF Plus
ETF Ticker	CUS1.L(GBP) LSE
ETF Ticker	CUSS.L(GBP) LSE